Page last updated: 2024-09-03

bq 610 and 20-hydroxy-5,8,11,14-eicosatetraenoic acid

bq 610 has been researched along with 20-hydroxy-5,8,11,14-eicosatetraenoic acid in 1 studies

Compound Research Comparison

Studies (bq 610)	Trials (bq 610)	Recent Studies (post-2010) (bq 610)	Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid)
124	1	3	640	13	233

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, S; Harder, DR; Koehler, RC; Kwansa, H; Roman, RJ; Wang, LC	1

Other Studies

1 other study(ies) available for bq 610 and 20-hydroxy-5,8,11,14-eicosatetraenoic acid

Article	Year
Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion. American journal of physiology. Regulatory, integrative and comparative physiology, 2009, Volume: 296, Issue:5 Topics: Amidines; Animals; Arterioles; Blood Substitutes; Blood Transfusion; Brain Ischemia; Endothelin A Receptor Antagonists; Endothelins; Hemoglobins; Hydroxyeicosatetraenoic Acids; Male; Models, Animal; Oligopeptides; Pia Mater; Polymers; Rats; Rats, Wistar; Regional Blood Flow; Vasodilation	2009

Article

Year

Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion.

American journal of physiology. Regulatory, integrative and comparative physiology, 2009, Volume: 296, Issue:5

Topics: Amidines; Animals; Arterioles; Blood Substitutes; Blood Transfusion; Brain Ischemia; Endothelin A Receptor Antagonists; Endothelins; Hemoglobins; Hydroxyeicosatetraenoic Acids; Male; Models, Animal; Oligopeptides; Pia Mater; Polymers; Rats; Rats, Wistar; Regional Blood Flow; Vasodilation

2009